Testing version — LOERadar is in active testing. Features and data may change.

OLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE; OLANZAPINE) | LOERadar

Viewing data from:

OLANZAPINE AND FLUOXETINE HYDROCHLORIDE

ANDA

FLUOXETINE HYDROCHLORIDE; OLANZAPINE | A077742 | PH HEALTH LTD

5 strengths0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 18, 2012	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (5)

Sort:

#001 — EQ 25MG BASE;EQ 3MG BASE

AB

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Nov 2, 2012

No patent or exclusivity listings for this strength.

#002 — EQ 25MG BASE;EQ 6MG BASE

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Nov 2, 2012

#003 — EQ 25MG BASE;EQ 12MG BASE

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Nov 2, 2012

#004 — EQ 50MG BASE;EQ 6MG BASE

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Nov 2, 2012

#005 — EQ 50MG BASE;EQ 12MG BASE

AB

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Nov 2, 2012